RXRX insider receives 156,658 shares in stock awards
By AlphaYouPublished Form 4
Hassan Fred
Reporting filer
Hassan Fred reported 156,658 shares of Class A Common Stock in RECURSION PHARMACEUTICALS, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 4, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Hassan Fred | 2026-11-02 | A | Grant or award | 156658 | 0 | 156,658 | 2 days | Filed terms
|
Class A Common Stock
- Owner
- Hassan Fred
- Date
- 2026-11-02
- Code
- A
- Action
- Grant or award
- Quantity
- 156658
- Price
- 0
- Following holdings
- 156,658
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Class A Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 156658
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- shares Owned Following Transaction: 156658
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hassan Fred: Director.
- F1: Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.
Original sources
Prepared automatically from public filing data. Report a correction.